Clinical trial

Study of Ferumoxytol Enhanced MRI for Detecting Lymph Node Metastases in Prostate, Bladder, and Kidney Cancers

NCT02141490

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2014-05-15

PhasePHASE2

Study timeline

Study start (actual)2014-05-15Date precision: day

Registry last updated2019-09-06

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Prostate Cancerunresolved

Bladder Cancerunresolved

Kidney Cancerunresolved

Interventions

FerumoxytolDRUG · verified · RxNorm: ferumoxytol

Magnetic Resonance Imaging (MRI)DIAGNOSTIC_TEST

Sponsors & collaborators

National Cancer Institute (NCI)lead sponsor

Mapped research locations

BethesdaMaryland, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02141490 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.